
Changes to Beneficiary Coinsurance When Colorectal Cancer Screenings Become Diagnostic
A small provision of the 2021 Consolidated Appropriations Act paves the way for Medicare patients to eventually pay no coinsurance for colorectal cancer screening tests when they become diagnostic. CMS finalized how that guideline will be enacted in the 2022 Medicare Physician Fee Schedule. READ MORE